Strategic Blueprint’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Strategic Blueprint's ELV Position: Q1 2026 in Review
Strategic Blueprint sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 608 shares — an estimated $213K sold.
Strategic Blueprint first reported a position in ELV in Q3 2019 and held it in 18 quarters. The position peaked at $424K in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Strategic Blueprint reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Strategic Blueprint sold 608 Elevance Health shares in Q1 2026, an estimated $213K.
- Strategic Blueprint first reported a position in Elevance Health in Q3 2019 and held it in 18 quarters.
- Strategic Blueprint's Elevance Health position peaked at $424K in Q1 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.